In this commentary, a team from Johns Hopkins Medicine writes about their experiences creating and implementing a digital health platform and explains how apps can contribute to improving patients’ health.
...
She talks about her research that examined the relative strength of associations between region, hospital, and patient characteristics with high-intensity statin use after myocardial...
Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
In this video, James Matera, MD, talks about the critical questions patients have about CKD, the impact of CKD on comorbid conditions and the need to limit risk, and more.
James Matera, MD, talks about the association between cardiometabolic diseases and hyperkalemia, the benefits and risks of various treatment approaches for chronic hyperkalemia, and more.
Florian Rader, MD, MSc, answers our questions regarding his new study on the ability of out-of-office and clinic blood pressure measurements to predict left ventricular hypertrophy in black Americans.
The STURDY study recently evaluated how OH timing is associated with dizziness in older patients. Coauthor Stephen P. Juraschek, MD, PhD, discusses these findings and how they compare with past...
New research investigated the usefulness of a mobile app in improving users’ adherence to the Dietary Approaches to Stop Hypertension diet. The researchers answered our burning questions about the app and...
In this editorial by Consultant Board Member Dr Michael Bloch, he reflects on a 1961 Consultant article about cardiovascular disease management and how it has affected him.
Mary Ann Hodorowicz, RDN, CDE, gives a preview of her upcoming Cardiometabolic Risk Summit talk on what clinicians can do to provide high-quality outpatient services related to cardiometabolic health, as...
